Nuzenio

Actimed

Actimed news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 8 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Actimed regains full control of S-oxprenolol after five-year partnership with Faraday - AllSciAllSci · Thu, 06 Aug 2026 16:48:50 GMT Actimed takes back all global rights to cachexia asset from Faraday - FirstWord PharmaFirstWord Pharma · Thu, 06 Aug 2026 14:56:57 GMT Actimed regains global rights to S-oxprenolol - The Pharma LetterThe Pharma Letter · Thu, 06 Aug 2026 13:52:58 GMT Actimed gets back rights to wasting disease drug, ending $126M deal with Faraday - fiercebiotech.comfiercebiotech.com · Thu, 06 Aug 2026 12:20:19 GMT Actimed retrieves ALS drug after Faraday collapse - European Biotechnology MagazineEuropean Biotechnology Magazine · Thu, 06 Aug 2026 12:13:31 GMT Actimed Therapeutics Reacquires Global Rights to S-oxprenolol, Broadening Pipeline Opportunity - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 07:15:12 GMT ACTIMED M (ACTIMEDM.MX) stock historical prices and data - Yahoo Finance UKYahoo Finance UK · Tue, 04 Aug 2026 23:59:41 GMT Actimed strengthens board with appointment of Dr Anders Ullman - Manufacturing ChemistManufacturing Chemist · Thu, 30 Jul 2026 13:03:34 GMT

Timeline

Thu, 06 Aug 2026 16:48:50 GMTActimed regains full control of S-oxprenolol after five-year partnership with Faraday - AllSci

Thu, 06 Aug 2026 14:56:57 GMTActimed takes back all global rights to cachexia asset from Faraday - FirstWord Pharma

Thu, 06 Aug 2026 13:52:58 GMTActimed regains global rights to S-oxprenolol - The Pharma Letter

Thu, 06 Aug 2026 12:20:19 GMTActimed gets back rights to wasting disease drug, ending $126M deal with Faraday - fiercebiotech.com

Thu, 06 Aug 2026 12:13:31 GMTActimed retrieves ALS drug after Faraday collapse - European Biotechnology Magazine

Thu, 06 Aug 2026 07:15:12 GMTActimed Therapeutics Reacquires Global Rights to S-oxprenolol, Broadening Pipeline Opportunity - The Manila Times

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Faraday6 live mentions The Pharma Letter3 live mentions European Biotechnology Magazine3 live mentions The Manila Times3 live mentions Yahoo Finance UK3 live mentions ALS2 live mentions Actimed Therapeutics Reacquires2 live mentions Global Rights2 live mentions Broadening Pipeline Opportunity2 live mentions ACTIMED M2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Actimed.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.